2016 非哺乳期乳腺炎诊治专家共识

2016-07-15 中华预防医学会妇女保健分会乳腺保健与疾病防治学组 中国实用外科杂志.2016,36(7):755-758.

中华预防医学会妇女保健分会乳腺保健与乳腺疾病防治学组撰写了《非哺乳期乳腺炎诊治专家共识(讨论稿)》,随后在威海、哈尔滨、北京等地组织会议,并邀请多位国内专家集体讨论,对于证据不足的争议问题,采用专家投票方式表决,最终形成建议或共识,并根据反馈意见再予以修订及完善,以供临床医师工作中参考。本共识旨在帮助临床医师为MOL 病人选择当前相对较好的诊治方案。在临床实践中,医师应参考治疗原则和新进展并结合

中文标题:

2016 非哺乳期乳腺炎诊治专家共识

发布日期:

2016-07-15

简要介绍:

中华预防医学会妇女保健分会乳腺保健与乳腺疾病防治学组撰写了《非哺乳期乳腺炎诊治专家共识(讨论稿)》,随后在威海、哈尔滨、北京等地组织会议,并邀请多位国内专家集体讨论,对于证据不足的争议问题,采用专家投票方式表决,最终形成建议或共识,并根据反馈意见再予以修订及完善,以供临床医师工作中参考。本共识旨在帮助临床医师为MOL 病人选择当前相对较好的诊治方案。在临床实践中,医师应参考治疗原则和新进展并结合病人具体病情进行个体化处理。

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 非哺乳期乳腺炎诊治专家共识)] GetToolGuiderByIdResponse(projectId=1, id=1679f1c0012a6654, title=2016 非哺乳期乳腺炎诊治专家共识, enTitle=, guiderFrom=中国实用外科杂志.2016,36(7):755-758., authorId=null, author=, summary= 中华预防医学会妇女保健分会乳腺保健与乳腺疾病防治学组撰写了《非哺乳期乳腺炎诊治专家共识(讨论稿)》,随后在威海、哈尔滨、北京等地组织会议,并邀请多位国内专家集体讨论,对于证据不足的争议问题,采用专家投票方式表决,最终形成建议或共识,并根据反馈意见再予以修订及完善,以供临床医师工作中参考。本共识旨在帮助临床医师为MOL 病人选择当前相对较好的诊治方案。在临床实践中,医师应参考治疗原则和新进展并结合, cover=, journalId=null, articlesId=null, associationId=934, associationName=中华预防医学会妇女保健分会乳腺保健与疾病防治学组, associationIntro=中华预防医学会妇女保健分会乳腺保健与疾病防治学组于2011年10月成立,委员为全国20多个省市的妇女保健界及乳腺专业的专家、学者,旨在针对乳腺良恶性疾病的防控、乳腺癌的早期诊断及规范化治疗在全国范围内进行多中心研究、培训及交流。希望经过努力建立起适合我国国情的乳腺癌高危人群模型并提供乳腺癌预防机制建议;为全国基层乳腺疾病工作者提供一个学习、交流的平台,以推动乳腺癌诊治规范化进程;规范乳腺良性疾病的诊断标准、干预措施,纠正目前对良性疾病的过度诊治现象,使广大妇女心身健康得到保护。, copyright=0, guiderPublishedTime=Fri Jul 15 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<div>中华预防医学会妇女保健分会乳腺保健与乳腺疾病防治学组撰写了《非哺乳期乳腺炎诊治专家共识(讨论稿)》,随后在威海、哈尔滨、北京等地组织会议,并邀请多位国内专家集体讨论,对于证据不足的争议问题,采用专家投票方式表决,最终形成建议或共识,并根据反馈意见再予以修订及完善,以供临床医师工作中参考。本共识旨在帮助临床医师为MOL 病人选择当前相对较好的诊治方案。在临床实践中,医师应参考治疗原则和新进展并结合病人具体病情进行个体化处理。</div> <div><br> 拓展指南:<strong>与<font color="red">乳腺炎</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=702d21c001082304" title="2014 ABM临床方案#4:乳腺炎(修订版)" target="_blank">2014 ABM临床方案#4:乳腺炎(修订版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c82bd1c001058588" title="非哺乳期乳腺炎症诊治共识(讨论稿)" target="_blank">非哺乳期乳腺炎症诊治共识(讨论稿)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E4%B9%B3%E8%85%BA%E7%82%8E" target="_blank">有关乳腺炎更多指南</a></ul></div>, tagList=[TagDto(tagId=36958, tagName=非哺乳期乳腺炎)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5833, appHits=421, showAppHits=0, pcHits=3919, showPcHits=2293, likes=192, shares=18, comments=7, approvalStatus=1, publishedTime=Fri Jul 29 17:21:36 CST 2016, publishedTimeString=2016-07-15, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Fri Jul 29 17:21:36 CST 2016, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 01:52:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 非哺乳期乳腺炎诊治专家共识)])
2016 非哺乳期乳腺炎诊治专家共识
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1009188, encodeId=1b0e1009188d4, content=拿点积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56e65547379, createdName=三尺微命, createdTime=Wed Aug 18 17:20:18 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920781, encodeId=f8c0920e81a0, content=好好学习一下,非常有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee115456804, createdName=ms2000001527146027, createdTime=Thu Jan 28 16:15:49 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918479, encodeId=94ae9184e948, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/3360b859ba944059aaffe8a1847ab57b/e91f325d086a40b2b9805211738111d1.jpg, createdBy=b3982392941, createdName=牟德武, createdTime=Wed Jan 20 17:43:45 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105199, encodeId=09301051994c, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:18:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95533, encodeId=3d5a9553338, content=学习了,抗结核治疗不知道效果怎样, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJDLicbdiao8d0vymSicFv4hYM7xuBbl2k4kA5oxnVBXkmQzoFZOK07PnLKAS9KGeoxOIM3uBWN0ZQhA/132, createdBy=86ba1929521, createdName=tinali1986, createdTime=Tue Aug 02 16:45:00 CST 2016, time=2016-08-02, status=1, ipAttribution=)]
    2021-08-18 三尺微命

    拿点积分

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1009188, encodeId=1b0e1009188d4, content=拿点积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56e65547379, createdName=三尺微命, createdTime=Wed Aug 18 17:20:18 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920781, encodeId=f8c0920e81a0, content=好好学习一下,非常有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee115456804, createdName=ms2000001527146027, createdTime=Thu Jan 28 16:15:49 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918479, encodeId=94ae9184e948, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/3360b859ba944059aaffe8a1847ab57b/e91f325d086a40b2b9805211738111d1.jpg, createdBy=b3982392941, createdName=牟德武, createdTime=Wed Jan 20 17:43:45 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105199, encodeId=09301051994c, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:18:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95533, encodeId=3d5a9553338, content=学习了,抗结核治疗不知道效果怎样, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJDLicbdiao8d0vymSicFv4hYM7xuBbl2k4kA5oxnVBXkmQzoFZOK07PnLKAS9KGeoxOIM3uBWN0ZQhA/132, createdBy=86ba1929521, createdName=tinali1986, createdTime=Tue Aug 02 16:45:00 CST 2016, time=2016-08-02, status=1, ipAttribution=)]
    2021-01-28 ms2000001527146027

    好好学习一下,非常有帮助。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1009188, encodeId=1b0e1009188d4, content=拿点积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56e65547379, createdName=三尺微命, createdTime=Wed Aug 18 17:20:18 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920781, encodeId=f8c0920e81a0, content=好好学习一下,非常有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee115456804, createdName=ms2000001527146027, createdTime=Thu Jan 28 16:15:49 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918479, encodeId=94ae9184e948, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/3360b859ba944059aaffe8a1847ab57b/e91f325d086a40b2b9805211738111d1.jpg, createdBy=b3982392941, createdName=牟德武, createdTime=Wed Jan 20 17:43:45 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105199, encodeId=09301051994c, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:18:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95533, encodeId=3d5a9553338, content=学习了,抗结核治疗不知道效果怎样, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJDLicbdiao8d0vymSicFv4hYM7xuBbl2k4kA5oxnVBXkmQzoFZOK07PnLKAS9KGeoxOIM3uBWN0ZQhA/132, createdBy=86ba1929521, createdName=tinali1986, createdTime=Tue Aug 02 16:45:00 CST 2016, time=2016-08-02, status=1, ipAttribution=)]
    2021-01-20 牟德武

    实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1009188, encodeId=1b0e1009188d4, content=拿点积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56e65547379, createdName=三尺微命, createdTime=Wed Aug 18 17:20:18 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920781, encodeId=f8c0920e81a0, content=好好学习一下,非常有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee115456804, createdName=ms2000001527146027, createdTime=Thu Jan 28 16:15:49 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918479, encodeId=94ae9184e948, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/3360b859ba944059aaffe8a1847ab57b/e91f325d086a40b2b9805211738111d1.jpg, createdBy=b3982392941, createdName=牟德武, createdTime=Wed Jan 20 17:43:45 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105199, encodeId=09301051994c, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:18:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95533, encodeId=3d5a9553338, content=学习了,抗结核治疗不知道效果怎样, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJDLicbdiao8d0vymSicFv4hYM7xuBbl2k4kA5oxnVBXkmQzoFZOK07PnLKAS9KGeoxOIM3uBWN0ZQhA/132, createdBy=86ba1929521, createdName=tinali1986, createdTime=Tue Aug 02 16:45:00 CST 2016, time=2016-08-02, status=1, ipAttribution=)]
    2016-08-27 1e0f7307m29(暂无匿称)

    实用,特别实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1009188, encodeId=1b0e1009188d4, content=拿点积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56e65547379, createdName=三尺微命, createdTime=Wed Aug 18 17:20:18 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920781, encodeId=f8c0920e81a0, content=好好学习一下,非常有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee115456804, createdName=ms2000001527146027, createdTime=Thu Jan 28 16:15:49 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918479, encodeId=94ae9184e948, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/3360b859ba944059aaffe8a1847ab57b/e91f325d086a40b2b9805211738111d1.jpg, createdBy=b3982392941, createdName=牟德武, createdTime=Wed Jan 20 17:43:45 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105199, encodeId=09301051994c, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:18:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95533, encodeId=3d5a9553338, content=学习了,抗结核治疗不知道效果怎样, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJDLicbdiao8d0vymSicFv4hYM7xuBbl2k4kA5oxnVBXkmQzoFZOK07PnLKAS9KGeoxOIM3uBWN0ZQhA/132, createdBy=86ba1929521, createdName=tinali1986, createdTime=Tue Aug 02 16:45:00 CST 2016, time=2016-08-02, status=1, ipAttribution=)]
    2016-08-02 tinali1986

    学习了,抗结核治疗不知道效果怎样

    0